Literature DB >> 6330591

Increased serum angiotensin-converting enzyme in chronic renal disease.

E Silverstein, J Brunswick, T K Rao, J Friedland.   

Abstract

Serum angiotensin-converting enzyme (SACE) was significantly elevated in 16 of 48 patients with various types of chronic renal disease not on hemodialysis [45.6 +/- (SD) 16.7 nmol/min/ml, p less than 0.001] and in 17 of 52 patients with chronic renal disease on maintenance hemodialysis (43.2 +/- 13.8, p less than 0.001) in comparison with 58 healthy adult controls (32.2 +/- 9.8). There was no significant relationship between SACE and renal function as indicated by serum creatinine and creatinine clearance, or the presence or absence of maintenance hemodialysis, except for a transiently increased elevation of SACE immediately post-dialysis due to hemoconcentration. There was a statistically insignificant positive correlation between SACE and 24-hour urinary protein excretion (r = 0.254, n = 21). Mean blood pressure measured in patients on maintenance hemodialysis was inversely related to SACE (p less than 0.05) following dialysis. Chronic renal disease irrespective of severity and therapy tends to be associated with elevated SACE and must be considered in the evaluation of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330591     DOI: 10.1159/000183246

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

2.  Changes of plasma angiotensin-converting enzyme activity during hemodialysis.

Authors:  W S Koo; Y J Lee; H S Kim; S Y Kim; E J Choi; Y S Chang; Y S Yoon; B K Bang
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

Review 3.  Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.

Authors:  Umar Malik; Veena Raizada
Journal:  Kidney Blood Press Res       Date:  2015-11-29       Impact factor: 2.687

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.